RECRUITING

Sleep Apnea in Elderly

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Sleep-disordered breathing (SDB or sleep apnea) is very common among elderly Veterans and leads to increased morbidity and mortality in this population. The proposal aims to identity whether oxygen, finasteride and acetazolamide can be effective in reducing unstable breathing and eliminating sleep apnea in the elderly via different mechanisms. This proposal will enhance the investigators' understanding of the pathways that contribute to the development of sleep apnea in the elderly. The investigators expect that the results obtained from this study will positively impact the health of Veterans by identifying new treatment modalities for sleep apnea. A cumulative effect of the investigators' research will fulfill the long-term goal of improving the quality of life of elderly Veterans suffering from sleep apnea and its potential life-threatening complications.

Official Title

Pathophysiology-Guided Therapy for Sleep Apnea in the Elderly

Quick Facts

Study Start:2015-07-03
Study Completion:2025-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02703220

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years to 89 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults who are 60 years old and older, with mild to moderate sleep apnea with AHI \>/=5 to 20/hr with central, obstructive, mixed apneas and hypopneas.
  2. * For the finasteride protocol elderly men with above criteria will be enrolled.
  1. * Patients with severe sleep apnea (AHI\>20/hr)
  2. * Patients with history of prostate cancer
  3. * Males with hypogonadism
  4. * History of cardiac disease, including myocardial infarction
  5. * Bypass surgery
  6. * Atrial and ventricular tachy-bradycardias
  7. * Systolic congestive heart failure and Cheyne-Stokes respiration
  8. * Current unstable angina
  9. * Stroke
  10. * Schizophrenia
  11. * Untreated hypothyroidism
  12. * Seizure disorder
  13. * Preexisting renal failure and liver disorders
  14. * Failure to give informed consent.
  15. * Patients with significant pulmonary diseases by history and abnormal pulmonary function testing, including moderate obstructive/restrictive lung/chest wall disorders with resting oxygen saturation of \<96% or on supplemental oxygen
  16. * Patients on certain medications including:
  17. * study drugs
  18. * sympathomimetics/parasympathomimetics or their respective blockers
  19. * narcotics
  20. * antidepressants
  21. * anti-psychotic agents
  22. * other central nervous system (CNS) altering medications
  23. * current alcohol, tobacco or recreational drug use
  24. * Patients with BMI\>34kg/m2 will be excluded to avoid the effects of morbid obesity on pulmonary mechanics and ventilatory control
  25. * Elderly with unstable gait or mobility issues that may preclude safe participation
  26. * Individuals with allergy to finasteride or acetazolamide will be excluded from the specific protocol
  27. * Pregnant women

Contacts and Locations

Study Contact

Ruchi Rastogi, MS
CONTACT
(313) 576-4464
ruchi.rastogi@va.gov

Principal Investigator

Susmita Chowdhuri, MD MS
PRINCIPAL_INVESTIGATOR
John D. Dingell VA Medical Center, Detroit, MI

Study Locations (Sites)

John D. Dingell VA Medical Center, Detroit, MI
Detroit, Michigan, 48201-1916
United States

Collaborators and Investigators

Sponsor: VA Office of Research and Development

  • Susmita Chowdhuri, MD MS, PRINCIPAL_INVESTIGATOR, John D. Dingell VA Medical Center, Detroit, MI

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-07-03
Study Completion Date2025-07-01

Study Record Updates

Study Start Date2015-07-03
Study Completion Date2025-07-01

Terms related to this study

Keywords Provided by Researchers

  • sleep apnea
  • chemoresponsiveness
  • cerebrovascular response
  • hyperoxia
  • acetazolamide
  • finasteride
  • apneic threshold
  • carbon-dioxide reserve

Additional Relevant MeSH Terms

  • Sleep Apnea
  • Elderly Adults